Othera Pharmaceuticals
Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Othera's lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full trial results due in mid-2010. The company is also developing novel treatments for glaucoma and neurodegenerative diseases.
7-day free trial · no credit card
Verified contacts
23
available on Kipplo
LinkedIn employees
31
11 to 50 range
Open roles
—
no listings
Distinct roles
19
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 23 verified contacts at Othera Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
23 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Othera Pharmaceuticals
19 distinct titles indexed · top 10 shown.
- 2pharmacist
- 1accountant
- 1assistant director
- 1best
- 1business development manager
- 1chairman & ceo
- 1data entry clerk
- 1executive
- 1ipqa in pharmaceutical
- 1ma
- +9more titles
Sign up to unlock all 23 contacts at Othera Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 23 verified contacts at Othera Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.